Survey Reveals 85% Percent of Patients Choose Compassion Over Pricing When Choosing a Doctor
HealthTap, a health technology company serving millions worldwide with its Health Operating System (HOPES™) powered by a network of 108,000 doctors and Artificial Intelligence, released a report today that revealed that compassion is more important than cost to patients (and doctors) when ranking doctors. In a climate where cost and access are often cited as key priorities among healthcare consumers and providers, this report indicates that despite rising healthcare costs and long wait times, both patients and doctors rank compassion as the most important element in healthcare today. In this survey on the role of compassion in medicine, 85% of patients reported that compassion was very important to them, whereas only 31% of respondents cited cost as being very important to them when making a healthcare decision. In comparison, wait time, which is often referenced as a key pain point for patients, only ranked at 48% in terms of being a very important factor in healthcare satisfaction. Most intriguing of all were the answers from the doctor respondents. 89% of doctors reported that compassion was a very important part of delivering the best care. This trumps even the importance doctors place on education and scholarly up-to-date command of medical knowledge (86%). In fact, 94% of the doctor respondents stated that compassionate makes their patients more likely to follow their advice, thus demonstrably improving health outcomes. “‘Compassion’ isn’t a word that you hear very often in Silicon Valley, but this survey proves that it’s the most important principle in healthcare,” said HealthTap Founder and CEO Ron Gutman. “The greater the role that technology and artificial intelligence play in healthcare, the greater the responsibility that we and other leading technologists have to build machines that value compassion just as much as doctors and patients do. We take that responsibility very seriously, and we have since the day I founded HealthTap in 2010. By teaching our technology how to practice and learn empathy, and by educating our employees and other stakeholders about the pivotal role compassion has in delivering the best health and care, we’re building a sustainable foundation to enable humans and machines to work in tandem to efficiently help billions everywhere live healthier, happier, and longer lives. That’s why compassion is the heart of our technology.” FULL SURVEY RESULTS:
- From doctors:
- 89% of doctors say compassion is very important.
- 86% of doctors say being knowledgeable (scholarly, up-to-date command of medical knowledge) is very important.
- 28% say short wait times are very important.
- 16% say low cost is very important.
- From patients:
- 85% of patients say compassion and listening carefully are very important.
- 85% of patients say being knowledgeable is very important.
- 48% of patients say short wait time is very important.
- 31% of patients say low cost is very important.
READ THE OP-ED FROM HEALTHTAP’S CEO:
https://www.healthtap.com/goto/compassion_op_ed
WATCH A VIDEO OF PATIENT STORIES:
https://www.healthtap.com/goto/compassion_video
ACCESS THE PRESS KIT:
https://www.healthtap.com/goto/compassion_presskit
About HealthTap HealthTap is the world's first Global Health Practice, delivering immediate healthcare, 24/7, from Query-to-Cure. HealthTap connects hundreds of millions of people in 174 countries via video, voice, and text chat on any mobile device or personal computer with health advice from a Medical Expert Network of more than 108,000 doctors across 147 specialties. HealthTap's proprietary Health Operating System (HOPES™) and proprietary, Artificial-Intelligence triaging technology (Dr. A.I.™) enable hospital systems, insurance companies, employers and governments to deliver the right care at the right time at the right price. HOPES is now powering the HealthTap Cloud™, a first-of-its-kind virtual cloud dedicated to healthcare and created for interoperability and ease of integration. Our mission is to help people live healthier,
happier
, longer lives.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
